Atlas Trials

Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger

Clinical trial NCT02145000 · COMPLETED

Trial details

NCT number
NCT02145000
Sponsor
Epicentre
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Severe Rotavirus Gastroenteritis
Start date
2014-06-01
Primary completion
2015-12-01
Enrollment
6586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.